A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Clinical trial NCT01640080 · COMPLETED

Trial details

NCT number: NCT01640080
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2012-06-27
Primary completion: 2013-06-03
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.